TABLE 1.
Demographic and Illness History Attributes of the Study Samplea
Variable | Total Study Sample (N=152) | |
---|---|---|
N | % | |
| ||
Sex (female) | 88 | 59 |
Race (nonwhite) | 8 | 5 |
Education (>1 year of college) | 83 | 56 |
Income (<$29,999) | 61 | 45 |
Marital status | ||
Married | 47 | 31 |
Unmarried | 56 | 37 |
Separated | 48 | 32 |
Family availability (yes) | 80 | 53 |
Diagnosis | ||
Bipolar I disorder | 105 | 69 |
Bipolar II disorder | 47 | 31 |
Prior manic episodes (>10) | 104 | 68 |
Prior depressive episodes (>10) | 103 | 69 |
Rapid cycling prior year (yes) | 42 | 30 |
Receiving medication (yes) | ||
Mood stabilizers | 130 | 96 |
Antidepressants | 43 | 32 |
Carbamazepine | 7 | 5 |
Lithium | 72 | 53 |
Lamotrigine | 37 | 27 |
Divalproex sodium | 46 | 34 |
Atypical antipsychotics | 41 | 30 |
Olanzapine/Quetiapine | 29 | 19 |
Anxiolytics | 27 | 20 |
| ||
Mean | SD | |
| ||
Age (years) | 41.09 | 11.37 |
Age at illness onset (years) | 15.68 | 8.02 |
Baseline Montgomery-Åsberg Depression Rating Scale scoreb | 21.50 | 9.97 |
Baseline Young Mania Rating Scale scoreb | 5.45 | 5.82 |
Depression summary scorec | 7.52 | 1.94 |
Mania summary scorec | 1.04 | 0.90 |
Baseline Global Assessment of Functioning score | 51.79 | 7.68 |
Duration of index major depressive episode (days) | 220.02 | 828.07 |
Baseline medication regimens were unavailable on 17 patients.
Refers to scores collected at intake into the study.
Refers to summary scores from the Clinical Monitoring Form (10) collected within 1 week of the date of randomization to psychosocial interventions.